Qube Research Q4 2025 13F: Quant Breadth With a Mega-Cap Core

Why This Q4 Filing Is Worth Reading

Qube Research & Technologies Ltd reported $98.44B of 13F assets for 2025Q4, with 500 displayed positions in the current holdings view and a WhaleScore of 58.75. This is not a single-stock manifesto. It is a scaled institutional filing, so the useful signal is the shape of exposure: which names dominate the dollars, how much of the portfolio sits in the first screen, and whether the same market factors show up across comparable filers.

The largest displayed holding was NVDA at $2.41B, equal to 2.91% of disclosed value. The top five represented about 11.3% of the portfolio, while the top ten represented about 18.2%. That is enough concentration to matter, but still broad enough that investors should read the filing as a diversified institutional book rather than a narrow hedge-fund bet.

The Top-Holdings Map

The top holdings show how heavily the current institutional market still leans on mega-cap technology, platform software, semiconductors, and large financial or consumer franchises. In this run, the generated fact pack does not provide a reliable prior-quarter position-change table, so this article treats the filing as a Q4 snapshot rather than claiming that each top row was a fresh purchase.

That caveat is important. A 13F snapshot can tell you where reported value sits today; it cannot, without a clean comparable baseline, prove intent. The current book still gives investors a useful risk map. A reader can compare NVDA, MSFT, AAPL, AMZN, and AVGO exposure across FIL Ltd, Schroder, Nordea, and Qube Research to see whether the same names are becoming crowded institutional defaults.

Concentration, Not Just Size

The top-five-versus-rest chart keeps the interpretation grounded. Qube Research & Technologies Ltd's first five displayed holdings made up roughly 11.3% of the filing, leaving about 88.7% in the remaining tail. That means the biggest names can still drive reported returns, but the book is not simply a one-stock or one-sector vehicle.

For retail investors, that distinction changes how the data should be used. Copying only the top few positions can create a much more concentrated portfolio than the filer actually reported. A better use is to identify which exposures are common across large institutions and then ask what catalyst could challenge the shared thesis.

The AUM Trend

The history table adds context to the current report. Recent values moved through 2025Q1 at $86.21B, 2025Q2 at $98.42B, 2025Q3 at $96.78B, 2025Q4 at $98.44B. Those moves can reflect price performance, reporting scope, amendments, and actual allocation changes. They should not be read as pure inflow or outflow without supporting evidence.

The Investor Takeaway

Qube Research & Technologies Ltd's Q4 2025 filing is most useful as a market-structure signal. It shows where a scaled institutional holder had its largest disclosed U.S.-listed equity exposure at quarter-end. The strongest takeaway is not that every top position is a new conviction buy; it is that mega-cap technology and related platform exposure remain the common language of large institutional portfolios.

Used correctly, this filing can help investors compare crowding, concentration, and portfolio breadth. Used incorrectly, it can tempt investors to clone a few large rows and miss the diversification, mandate, and reporting context that made the original filing look the way it did.